单剂量异环磷酰胺：非小细胞肺癌的疗效研究。 - Suppr

Suppr

超能文献

Single-dose ifosfamide: efficacy studies in non-small cell lung cancer.

作者信息

Harrison E F, Hawke J E, Hunter H L, Costanzi J J, Morgan L R, Plotkin D, Tucker W G, Worrall P M

出版信息

Semin Oncol. 1982 Dec;9(4 Suppl 1):56-60.

PMID:6298944

Abstract

摘要

相似文献

Single-dose ifosfamide: efficacy studies in non-small cell lung cancer.单剂量异环磷酰胺：非小细胞肺癌的疗效研究。

Semin Oncol. 1982 Dec;9(4 Suppl 1):56-60.

Ifosfamide in the treatment of extensive non-oat cell carcinoma of the lung.异环磷酰胺治疗广泛期非小细胞肺癌

Semin Oncol. 1982 Dec;9(4 Suppl 1):61-5.

Use and safety of high-dose ifosfamide.大剂量异环磷酰胺的使用与安全性。

Semin Oncol. 1982 Dec;9(4 Suppl 1):78-86.

Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma.

Cancer Treat Rep. 1981 Jul-Aug;65(7-8):693-5.

[Ifosfamide in the treatment of small cell carcinoma of the lung].异环磷酰胺治疗肺癌小细胞癌

Gan To Kagaku Ryoho. 1983 May;10(5):1293-8.

Ifosfamide in the treatment of recurrent or disseminated lung cancer: a phase II study of two dose schedules.异环磷酰胺治疗复发性或播散性肺癌：两种剂量方案的II期研究

Cancer. 1978 May;41(5):1715-9. doi: 10.1002/1097-0142(197805)41:5<1715::aid-cncr2820410510>3.0.co;2-x.

Phase I clinical study of acetylcysteine's preventing ifosfamide-induced hematuria.乙酰半胱氨酸预防异环磷酰胺所致血尿的I期临床研究

Semin Oncol. 1983 Mar;10(1 Suppl 1):62-5.

Pilot study of intravenous ifosfamide plus oral acetylcysteine in the treatment of non-small cell lung cancer.静脉注射异环磷酰胺联合口服乙酰半胱氨酸治疗非小细胞肺癌的初步研究

Vet Hum Toxicol. 1981;23(Suppl 1):12-4.

Prophylaxis of ifosfamide toxicity with oral acetylcysteine.口服乙酰半胱氨酸预防异环磷酰胺毒性

Semin Oncol. 1983 Mar;10(1 Suppl 1):66-71.

[Chemotherapy of the non-small cell carcinoma of the lung with ifosfamide and cisplatin].异环磷酰胺和顺铂用于非小细胞肺癌的化疗

Dtsch Med Wochenschr. 1984 Jul 6;109(27):1059-64. doi: 10.1055/s-2008-1069324.

引用本文的文献

Lung cancer in the elderly: current and future chemotherapeutic options.

Drugs Aging. 2002;19(5):365-75. doi: 10.2165/00002512-200219050-00005.

Chemotherapy in non-small cell lung cancer.非小细胞肺癌的化疗

Invest New Drugs. 2000 May;18(2):157-86. doi: 10.1023/a:1006330030333.

Enhancement of sensitivity of human lung adenocarcinoma cells to growth-inhibitory activity of interferon alpha by differentiation-inducing agents.分化诱导剂增强人肺腺癌细胞对α-干扰素生长抑制活性的敏感性。

Br J Cancer. 1996 Aug;74(4):546-54. doi: 10.1038/bjc.1996.399.

Chemotherapy in non-small cell bronchial carcinoma.非小细胞支气管癌的化疗

Thorax. 1985 Sep;40(9):641-5. doi: 10.1136/thx.40.9.641.

A phase II study of ifosfamide in children with recurrent solid tumours.

Cancer Chemother Pharmacol. 1985;15(3):258-62. doi: 10.1007/BF00263897.

Single-agent chemotherapy for advanced adenocarcinoma of the lung. A review.晚期肺腺癌的单药化疗。综述。

Cancer Chemother Pharmacol. 1988;21(2):89-102. doi: 10.1007/BF00257354.

Ifosfamide by bolus as treatment for advanced non-small cell lung cancer.大剂量异环磷酰胺治疗晚期非小细胞肺癌。

Cancer Chemother Pharmacol. 1986;18 Suppl 2:S30-3. doi: 10.1007/BF00647448.

Evaluation of a new drug 7-N-(p-hydroxyphenyl)-mitomycin C [KW 2083] against carcinoma of the lung by the human tumor clonogenic assay.通过人肿瘤克隆形成试验评估新型药物7-N-（对羟基苯基）-丝裂霉素C[KW 2083]对肺癌的疗效。

Invest New Drugs. 1985;3(4):341-7. doi: 10.1007/BF00170756.

Failure of response to ifosfamide in squamous cell bronchogenic carcinoma.鳞状细胞支气管癌对异环磷酰胺无反应

Cancer Chemother Pharmacol. 1989;23(2):128. doi: 10.1007/BF00273534.

A phase II study of ifosfamide in paediatric solid tumours.

Cancer Chemother Pharmacol. 1989;24 Suppl 1:S13-5. doi: 10.1007/BF00253231.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验